The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010).

摘要

A long-term follow-up report of regional hyperthermia and concurrent chemoradiation (triple therapy) in advanced cervical cancer showed that complete remission was achieved in 32 patients (88%) (Westermann et al.). After a median follow-up of 62 months (range, 6-97 months), 12 patients were died of disease and one has been alive with disease. The 5-year disease-free survival and overall survival was 66% (95% CI: 52, 84) and 74% (95% CI: 60, 90), respectively, with acceptable toxicity. Although further improvement of advanced cervical cancer may benefit with better local-regional control, we should continue to discover better systemic agents in this group of patients.